564 related articles for article (PubMed ID: 26613630)
1. [Mucopolysaccharidosis: clinical features, diagnosis and management].
Suarez-Guerrero JL; Gómez Higuera PJ; Arias Flórez JS; Contreras-García GA
Rev Chil Pediatr; 2016; 87(4):295-304. PubMed ID: 26613630
[TBL] [Abstract][Full Text] [Related]
2. Clinical and laboratorial study of 19 cases of mucopolysaccharidoses.
Albano LM; Sugayama SS; Bertola DR; Andrade CE; Utagawa CY; Puppi F; Nader HB; Toma L; Coelho J; Leistner S; Burin M; Giugliani R; Chong AK
Rev Hosp Clin Fac Med Sao Paulo; 2000; 55(6):213-8. PubMed ID: 11313661
[TBL] [Abstract][Full Text] [Related]
3. Therapy for the mucopolysaccharidoses.
Valayannopoulos V; Wijburg FA
Rheumatology (Oxford); 2011 Dec; 50 Suppl 5():v49-59. PubMed ID: 22210671
[TBL] [Abstract][Full Text] [Related]
4. Mucopolysaccharidoses and the eye.
Ashworth JL; Biswas S; Wraith E; Lloyd IC
Surv Ophthalmol; 2006; 51(1):1-17. PubMed ID: 16414358
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic screening for mucopolysaccharidoses by the dimethylmethylene blue method and two dimensional electrophoresis.
Chuang CK; Lin SP; Chung SF
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):15-22. PubMed ID: 11310367
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.
Lau AA; Hemsley KM
J Mol Med (Berl); 2017 Oct; 95(10):1043-1052. PubMed ID: 28660346
[TBL] [Abstract][Full Text] [Related]
7. Further electroretinographic studies of patients with mucopolysaccharidoses.
Leung LS; Weinstein GW; Hobson RR
Birth Defects Orig Artic Ser; 1971 Mar; 7(3):32-40. PubMed ID: 5006141
[TBL] [Abstract][Full Text] [Related]
8. Implementation of an Affordable Method for MPS Diagnosis from Urine Screening to Enzymatic Confirmation: Results of a Pilot Study in Morocco.
Fdil N; Sabir ES; Ezoubeiri A; Elqadiry R; Daoudi A; Lalaoui A; Fouad A; Rada N; Slitine N; Bennaoui F; Bourrahouat A; Saab IA; Boualy B; Karim A; Andrade F; González-Lamuňo D; Aldámiz-Echevarria L; Bouskraoui M
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162878
[TBL] [Abstract][Full Text] [Related]
9. Incidence of the mucopolysaccharidoses in Northern Ireland.
Nelson J
Hum Genet; 1997 Dec; 101(3):355-8. PubMed ID: 9439667
[TBL] [Abstract][Full Text] [Related]
10. Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis.
McGrath O; Sornalingam K; Aslam T; Ashworth J
Cornea; 2023 Aug; 42(8):992-999. PubMed ID: 36857777
[TBL] [Abstract][Full Text] [Related]
11. Urinary glycosaminoglycans as a potential biomarker for evaluating treatment efficacy in subjects with mucopolysaccharidoses.
Kakkis E; Marsden D
Mol Genet Metab; 2020 May; 130(1):7-15. PubMed ID: 32224020
[TBL] [Abstract][Full Text] [Related]
12. Mucopolysaccharidoses - Clinical Spectrum and Frequency of Different Types.
Cheema HA; Malik HS; Hashmi MA; Fayyaz Z; Mushtaq I; Shahzadi N
J Coll Physicians Surg Pak; 2017 Feb; 27(2):80-83. PubMed ID: 28292383
[TBL] [Abstract][Full Text] [Related]
13. Functional capacity evaluation of patients with mucopolysaccharidosis.
Guarany NR; Schwartz IV; Guarany FC; Giugliani R
J Pediatr Rehabil Med; 2012; 5(1):37-46. PubMed ID: 22543891
[TBL] [Abstract][Full Text] [Related]
14. Stability of urinary glycosaminoglycans in patients with mucopolysaccharidoses.
Andrade F; Prieto JA; Elorz J; Martín S; Sanjurjo P; Aldámiz-Echevarría L
Clin Chim Acta; 2008 Feb; 388(1-2):73-7. PubMed ID: 17964291
[TBL] [Abstract][Full Text] [Related]
15. [Neurologic manifestations in mucopolysaccharidoses].
Héron B
Arch Pediatr; 2014 Jun; 21 Suppl 1():S14-21. PubMed ID: 25063379
[TBL] [Abstract][Full Text] [Related]
16. Cumulative incidence rates of the mucopolysaccharidoses in Germany.
Baehner F; Schmiedeskamp C; Krummenauer F; Miebach E; Bajbouj M; Whybra C; Kohlschütter A; Kampmann C; Beck M
J Inherit Metab Dis; 2005; 28(6):1011-7. PubMed ID: 16435194
[TBL] [Abstract][Full Text] [Related]
17. [Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts].
Giugliani R; Federhen A; Muñoz Rojas MV; Vieira TA; Artigalás O; Pinto LL; Azevedo AC; Acosta AX; Bomfim C; Lourenço CM; Kim CA; Horovitz D; Souza DB; Norato D; Marinho D; Palhares D; Santos ES; Ribeiro E; Valadares ER; Guarany F; De Lucca GR; Pimentel H; Souza IN; Corrêa Neto J; Fraga JC; Góes JE; Cabral JM; Simeonato J; Llerena JC; Jardim LB; Giuliani Lde R; Silva LC; Santos M; Moreira MA; Kerstenetzky M; Ribeiro M; Ruas N; Barrios P; Aranda P; Honjo R; Boy R; Costa R; Souza CF; Alcântara FF; Avilla SG; Fagondes S; Martins AM
Rev Assoc Med Bras (1992); 2010; 56(3):271-7. PubMed ID: 20676532
[TBL] [Abstract][Full Text] [Related]
18. [Mucopolysaccharidosis: A review].
Michaud M; Belmatoug N; Catros F; Ancellin S; Touati G; Levade T; Gaches F
Rev Med Interne; 2020 Mar; 41(3):180-188. PubMed ID: 31959364
[TBL] [Abstract][Full Text] [Related]
19. Clinical response to long term enzyme replacement treatment in children, adolescent and adult patients with Hunter syndrome.
Dalmau Serra J; Vitoria Miñana I; Calderón Fernández R; Cortell Aznar I
Med Clin (Barc); 2015 Nov; 145(9):392-8. PubMed ID: 26360015
[TBL] [Abstract][Full Text] [Related]
20. Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?
Węgrzyn G; Jakóbkiewicz-Banecka J; Narajczyk M; Wiśniewski A; Piotrowska E; Gabig-Cimińska M; Kloska A; Słomińska-Wojewódzka M; Korzon-Burakowska A; Węgrzyn A
Med Hypotheses; 2010 Dec; 75(6):605-9. PubMed ID: 20732748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
